TX-SOFTSERVE
SoftServe, a leader in digital services and consulting, has been recognized as an Aspirant in Everest Group's Life Sciences Digital Services PEAK Matrix® Assessment 2022. Everest Group is a provider of strategic research insights on IT, business processes, and engineering services and a global Business Process Outsourcing (BPO) research firm.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005890/en/
Everest Group Recognizes SoftServe as a Key Player in Digital Services within the Life Sciences Landscape (Graphic: Business Wire)
The Life Sciences Digital Services PEAK Matrix® Assessment 2022 covers the top digital life sciences service providers, best-in-class solutions and products, and top locations, according to Everest Group's research. This is the first time SoftServe has been named in the Life Sciences sector.
SoftServe debuted with an impressive score in Everest Group's two assessment areas: vision and strategy along with value delivered. Everest Group recognized SoftServe’s expertise in a consulting-led approach to deliver AI and analytics-based domain-specific digital platforms and custom solutions with accelerators, including Human360°, data management, and omnichannel engagement. SoftServe was also recognized for strategic initiatives in talent upskilling through investments in SoftServe University, data and analytics CoE, and professional certifications.
“Since the pandemic we have seen a rapid increase in transitioning legacy systems to strategic digital solutions, especially in the life sciences vertical,” said Steve LoSardo, vice president of Life Science Domain Solutions and Consulting, SoftServe. “Clients are seeking innovative partners to guide them in making the right decisions, create solutions to solve specific business issues and build effective long-term digital strategies and that is exactly how SoftServe operates. This assessment displays our deep expertise across biopharmaceutical and medical device enterprises, and our reputation for delivering excellence through quality talent and products.”
Everest Group specifically called out biopharmaceutical and medical devices enterprise clients and acknowledged SoftServe’s delivery excellence and quality of talent as key strengths. Download the full report.
SoftServe has also been recognized as a Major Contender in the Healthcare Analytics Services PEAK Matrix® Assessment, the Healthcare Payer Digital Services PEAK Matrix® Assessment, and the Digital Product Engineering Services PEAK Matrix® Assessment.
About SoftServe
SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize how enterprises and software companies do business. Our end-to-end solutions and expertise deliver innovation, quality, and speed across the healthcare, retail, energy, manufacturing, and financial services verticals. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s marketplace—no matter where you are in your journey.
Visit our website, blog, LinkedIn, Facebook, and Twitter pages.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005890/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MA-RENAGADE-THERAPEUTICS27.4.2024 02:10:34 CEST | Press release
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
NY-HCLTECH26.4.2024 22:07:31 CEST | Press release
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY
KINAXIS-INC.26.4.2024 18:04:28 CEST | Press release
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions
VERTEX-PHARMA26.4.2024 17:44:28 CEST | Press release
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
SUZANO-S.A.26.4.2024 17:23:27 CEST | Press release
Suzano 2023 annual report on Form 20-F
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom